Pulmonx Corporation

Pulmonx Corporation is a global leader in interventional pulmonology, specializing in the assessment and treatment of severe lung diseases. They are best known for their Zephyr® Valve, a minimally invasive, FDA-approved treatment for patients with severe COPD/emphysema who experience shortness of breath despite medication. The Zephyr Valve reduces lung hyperinflation by allowing trapped air to escape, improving lung function and breathing. Pulmonx also offers the StratX® Lung Analysis Reports, a cloud-based service using CT scans to identify target lobes for Zephyr Valve treatment, and the Chartis® Pulmonary Assessment System, a balloon catheter that measures flow and pressure to assess collateral ventilation.

Pulmonx is dedicated to improving the lives of patients suffering from advanced lung disease through innovation and the development of evidence-based solutions. The company is committed to building further clinical evidence across patient phenotypes to support the use of its technologies. Pulmonx products are commercially available in Europe, the United States, Australia, Asia, Latin America, and other countries worldwide.

Pulmonx Corporation offers a competitive benefits package to its employees, including comprehensive medical, dental, and vision insurance. They also provide a 401k plan, an Employee Assistance Program, flexible spending accounts, dependent care benefits, tuition reimbursement, a commuter program, an equity program, an employee referral bonus, and other perks.

Pulmonx Corporation is a global leader in interventional pulmonology, dedicated to improving the breathing and quality of life for patients suffering from severe lung disease. They strive to be the trusted partner in the assessment and treatment of such diseases by innovating and commercializing evidence-based solutions, putting patient focus at the center of their decisions, and fostering a collaborative environment that prioritizes science, innovation, and global collaboration.

Pulmonx promotes a culture focused on patient well-being, prioritizing innovation and scientific data to drive decision-making and commercial execution. They value global collaboration and encourage diverse perspectives within their teams. A sense of urgency and accountability are also emphasized, aiming to deliver on commitments with integrity and transparency. This results in a work environment that values both individual contributions and teamwork, fostering a culture of continuous improvement and shared success in improving the lives of patients with severe lung disease.

Pulmonx Corporation is committed to fostering a diverse, equitable, and inclusive workplace. The company actively embraces diversity in its workforce and actively seeks to create a culture where all individuals feel valued, respected, and empowered. This commitment is reflected in their mentoring program for diverse students interested in health technology and their equal opportunity employment policy. Pulmonx recognizes the importance of diverse perspectives and actively strives to create a workplace that is welcoming and inclusive for all.